NewsWire

Value Guru Surrounds News Corp., Jumps Into Biotech

By The Street on February 15th, 2012

Seth Klarman, founder of -based hedge fund Baupost Group , made only one big new bet in the fourth quarter: a small biopharmaceutical company called Targacept (TRGT), according to the fund?s latest 13F filing. Klarman is a strict value investor who manages more than $20 billion and prefers to stay out of the media spotlight. ...